Fig. 1From: A blood-based composite panel that screens Alzheimer’s diseaseIndividual plasma level of four biomarkers in a discovery cohort. A-D show levels of sLRP1, KLK4, GSN and Caspase 3. *P < 0.05, **P < 0.01, ***P < 0.001Back to article page